Literature DB >> 17346171

Enzymes in the conversion of cholesterol into bile acids.

Maria Norlin1, Kjell Wikvall.   

Abstract

This article aims to give an overview on the characterization, properties and regulation of enzymes, particularly the cytochrome (CYP) P450 enzymes, in the formation of bile acids from cholesterol. Bile acids are biologically active molecules that promote absorption of dietary lipids in the intestine and stimulate biliary excretion of cholesterol. Bile acids and oxysterols, formed from cholesterol, act as ligands to nuclear receptors regulating the expression of important genes in cholesterol homeostasis. Thus, the bioactivation of cholesterol into bile acids is crucial for regulation of cholesterol homeostasis. The primary human bile acids, cholic acid and chenodeoxycholic acid, are formed from cholesterol via several pathways involving many different enzymes. Many of these enzymes are cytochrome P450 (CYP) enzymes, introducing a hydroxyl group in the molecule. The "classic" pathway of bile acid formation starts with a 7alpha-hydroxylation of cholesterol by CYP7A1 in the liver. The "acidic" pathway starts with a hepatic or extrahepatic 27-hydroxylation by CYP27A1. There also exist some quantitatively minor pathways which may be of importance under certain conditions. Formation of cholic acid requires insertion of a 12alpha-hydroxyl group performed by CYP8B1. Oxysterols are precursors to bile acids, participate in cholesterol transport and are known to affect the expression of several genes in cholesterol homeostasis. Enzymes with capacity to form and metabolize oxysterols are present in liver and extrahepatic tissues. The enzymes, nuclear receptors and transcription factors involved in bile acid biosynthesis are potential pharmaceutical targets for the development of new drugs to control hypercholesterolemia and to prevent atherosclerosis and other diseases related to disturbed cholesterol homeostasis. The review will also discuss some inborn errors of bile acid biosynthesis and the recently acquired knowledge on the genetic defects underlying these diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346171     DOI: 10.2174/156652407780059168

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  56 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

Review 2.  Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration.

Authors:  Ignacio R Rodríguez; Ignacio M Larrayoz
Journal:  J Lipid Res       Date:  2010-06-21       Impact factor: 5.922

3.  Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.

Authors:  Olga V Fedorova; Valentina I Zernetkina; Victoria Y Shilova; Yulia N Grigorova; Ondrej Juhasz; Wen Wei; Courtney A Marshall; Edward G Lakatta; Alexei Y Bagrov
Journal:  Circ Cardiovasc Genet       Date:  2015-09-15

Review 4.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

5.  Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.

Authors:  Qi Zhang; Guang-ji Wang; Ji-ye A; Di Wu; Ling-ling Zhu; Bo Ma; Yu Du
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

6.  Role of cholesterol pathways in norovirus replication.

Authors:  Kyeong-Ok Chang
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.

Authors:  Masaaki Miyata; Yoshiki Matsuda; Masahiro Nomoto; Yuki Takamatsu; Nozomi Sato; Mayumi Hamatsu; Paul A Dawson; Frank J Gonzalez; Yasushi Yamazoe
Journal:  Drug Metab Dispos       Date:  2008-11-06       Impact factor: 3.922

8.  Evolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites.

Authors:  Lee R Hagey; Nicolas Vidal; Alan F Hofmann; Matthew D Krasowski
Journal:  BMC Evol Biol       Date:  2010-05-06       Impact factor: 3.260

9.  The bile acid synthesis pathway is present and functional in the human ovary.

Authors:  Laura P Smith; Maik Nierstenhoefer; Sang Wook Yoo; Alan S Penzias; Edda Tobiasch; Anny Usheva
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

10.  Different responsiveness to a high-fat/cholesterol diet in two inbred mice and underlying genetic factors: a whole genome microarray analysis.

Authors:  Mingzhe Zhu; Guozhen Ji; Gang Jin; Zuobiao Yuan
Journal:  Nutr Metab (Lond)       Date:  2009-10-17       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.